Diagnostics

Anti-CRO Lindus Health Raises $55M in Series B Funding to Transform the Clinical Trial Landscape

Lindus Health is the 'anti-CRO' fixing the broken clinical trial industry, setting the stage for greater scientific innovation and lower…

11 months ago

BIRD – Israel-U.S. Binational Industrial R&D Foundation to Invest $6 Million in 5 New Projects

The approved projects, with an overall budget of $15 million, involve innovations in Electronics, Healthcare, Medical Devices, and Quantum Computing…

11 months ago

BioHarvest Announces Appointment of Sharon Malka to Board of Directors

Veteran Technology Leader Brings 25+ Years of Financial and Capital Markets Experience to the BoardVancouver, British Columbia and Rehovot, Israel--(Newsfile…

11 months ago

BioHarvest Announces Appointment of Sharon Malka to Board of Directors

Veteran Technology Leader Brings 25+ Years of Financial and Capital Markets Experience to the BoardVancouver, British Columbia and Rehovot, Israel--(Newsfile…

11 months ago

Spectral AI Provides Update to Investors

DALLAS, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), developer of the AI-driven…

11 months ago

DiagnaMed and TerraVent Announce Strategic Collaboration for Next-Generation Clean Hydrogen Production

TORONTO, Jan. 22, 2025 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a leading…

11 months ago

NFL Alumni Joel Dreessen and Le-Lo Lang Team Up With HeartFlow and Boone Heart Institute to Launch GAMEFILM Registry to Assess Heart Disease Risks in Retired Football Players

Registry will use HeartFlow FFRCT and Plaque Analysis to help inform strategies for prevention, earlier detection and improved care for…

11 months ago

ProPhase Labs Announces Closing of $23.6 Million Sale of Pharmaloz Manufacturing to Houston-Based Private Equity Firm

Transaction Eliminates More Than $20 Million in Debt, and Other Financial Obligations, Provides $2 million in Cash and Significantly Enhances…

11 months ago

MedMira Receives Investigational Testing Authorizations for Multiplo(R) TP/HIV Self-Test and Non-Professional Use Applications

HALIFAX, NS / ACCESS Newswire / January 21, 2025 / MedMira Inc. (MedMira) (TSXV:MIR) announced today that it has received…

11 months ago